(lp0
S'The Medicines Company  Breaks into New 52-Week High on March 15 Session Equities.com - 12 hours ago Shares of The Medicines Company  broke into a new 52-week high yesterday, hitting a peak of $54.89. Shares closed at $54.41 after opening at $52.64 for a move of 4.01%.'
p1
aS"The Medicines Company to Webcast Presentation of ORION-1 Phase II Study of ... Business Wire  - Mar 14, 2017 PARSIPPANY, N.J.----The Medicines Company  today announced that it will webcast, over the internet simultaneously with the presentation, the detailed results from its ORION-1 Phase II study of inclisiran, the Company's&nbsp;..."
p2
aS"The Medicines Company to Host Conference Call and Webcast at Upcoming American ... Yahoo Finance - Mar 6, 2017 The Medicines Company  will host a conference call and webcast on Friday, March 17, 2017, at 3:30 p.m., Eastern Time, to review data from the ORION-1 Phase II study of inclisiran, the Company's PCSK9 synthesis inhibitor."
p3
aS'Earnings Reaction History: The Medicines Company, 44.4% Follow-Through ... Nasdaq - Feb 28, 2017 The Medicines Company  is due to issue its quarterly earnings report in the upcoming extended-hours session. Given its history, traders can expect light trading in the issue immediately following its quarterly earnings announcement.'
p4
aS'The Medicines Company Partnering Deals and Alliances 2010 to 2017 PR Newswire  - Feb 27, 2017 Chapter 1 provides an introduction to the report, whilst chapter 2 lists the top companies partnering with the company since 2010. Chapter 3 provides an overview of the leading partnering and M&amp;A deals since 2010 to present date based on headline value.'
p5
aS'The Medicines Company Reports Fourth-Quarter and Full-Year 2016 Financial Results Yahoo Finance - Feb 28, 2017 Driven by strong execution against our strategic priorities, 2016 was a transformative year for the Company, said Clive Meanwell, M.D.'
p6
aS"The Medicines Company Announces FDA Filing Acceptance of New Drug Application ... Yahoo Finance - Feb 21, 2017 The Medicines Company  today announced that the U.S. Food and Drug Administration  has accepted for priority review the Company's new drug application  filing for Carbavance  for the treatment of&nbsp;..."
p7
aS'Medicines Company  Q4 Loss Narrower than Expected Yahoo Finance - Mar 1, 2017 The Medicines Company MDCO reported a loss of $1.29 per share  in the fourth quarter of 2016, narrower than Zacks Consensus Estimate of a loss of $1.43.The Medicines Company  Files An 8-K Results of Operations and ... - Market ExclusiveAverage Brokerage Rating Of GrubHub Inc. , The Medicines Company  - The USA Commerce'
p8
aS'The Medicines Company to Announce Fourth-Quarter and Full-Year 2016 Financial ... Yahoo Finance - Feb 17, 2017 The Medicines Company is a biopharmaceutical company driven by an overriding purpose - to save lives, alleviate suffering and contribute to the economics of healthcare.'
p9
aS'Why Investors remained confident on The Medicines Company , Apple ... StockNewsJournal - Mar 8, 2017 The Medicines Company  have shown a high EPS growth of -22.20% in the last 5 years and has earnings decline of 48.60% yoy.'
p10
a.